Jundishapur Journal of Natural Pharmaceutical Products

Published by: Kowsar

The Effect of Date Seed (Phoenix dactylifera) Extract on Paraoxonase and Arylesterase Activities in Hypercholesterolemic Rats

Mohammad Reza Takaeidi 1 , Alireza Jahangiri 2 , Mohammad Javad Khodayar 3 , * , Amir Siahpoosh 1 , 4 , Hamid Yaghooti 5 , Saeid Rezaei 6 , Maryam Salecheh 1 and Zahra Mansourzadeh 1
Authors Information
1 Medicinal Plants and Natural Products Research Center, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Department of Medicinal Chemistry and Nanotechnology center, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
3 Department of Pharmacology and Toxicology Research Center, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
4 Department of Pharmacognosy, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
5 Department of Medical Laboratory Sciences, School of Allied Medical Sciences Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
6 Department of Pharmaceutics, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, IR Iran
Article information
  • Jundishapur Journal of Natural Pharmaceutical Products: February 01, 2014, 9 (1); 30-34
  • Published Online: February 10, 2014
  • Article Type: Research Article
  • Received: January 20, 2013
  • Revised: August 11, 2013
  • Accepted: October 8, 2013
  • DOI: 10.17795/jjnpp-10368

To Cite: Takaeidi M R, Jahangiri A, Khodayar M J, Siahpoosh A, Yaghooti H, et al. The Effect of Date Seed (Phoenix dactylifera) Extract on Paraoxonase and Arylesterase Activities in Hypercholesterolemic Rats, Jundishapur J Nat Pharm Prod. 2014 ; 9(1):30-34. doi: 10.17795/jjnpp-10368.

Abstract
Copyright © 2014, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Costa LG, Giordano G, Furlong CE. Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on. Biochem Pharmacol. 2011; 81(3): 337-44[DOI][PubMed]
  • 2. Costa LG, Richter RJ, Li WF, Cole T, Guizzetti M, Furlong CE. Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity. Biomarkers. 2003; 8(1): 1-12[DOI][PubMed]
  • 3. Aviram M. Introduction to paraoxonases. J Lipids. 2012; 2012: 1-3[DOI][PubMed]
  • 4. Androutsopoulos VP, Kanavouras K, Tsatsakis AM. Role of paraoxonase 1 (PON1) in organophosphate metabolism: implications in neurodegenerative diseases. Toxicol Appl Pharmacol. 2011; 256(3): 418-24[DOI][PubMed]
  • 5. Camps J, Marsillach J, Joven J. The paraoxonases: role in human diseases and methodological difficulties in measurement. Crit Rev Clin Lab Sci. 2009; 46(2): 83-106[DOI][PubMed]
  • 6. Camps J, Marsillach J, Joven J. Pharmacological and lifestyle factors modulating serum paraoxonase-1 activity. Mini Rev Med Chem. 2009; 9(8): 911-20[PubMed]
  • 7. Costa LG, Vitalone A, Cole TB, Furlong CE. Modulation of paraoxonase (PON1) activity. Biochem Pharmacol. 2005; 69(4): 541-50[DOI][PubMed]
  • 8. Tomas M, Senti M, Garcia-Faria F, Vila J, Torrents A, Covas M, et al. Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients. Arterioscler Thromb Vasc Biol. 2000; 20(9): 2113-9
  • 9. van Wijk J, Coll B, Cabezas MC, Koning E, Camps J, Mackness B, et al. Rosiglitazone modulates fasting and post-prandial paraoxonase 1 activity in type 2 diabetic patients. Clin Exp Pharmacol Physiol. 2006; 33(12): 1134-7[DOI][PubMed]
  • 10. Wojcicka G, Jamroz-Wisniewska A, Marciniak A, Lowicka E, Beltowski J. The differentiating effect of glimepiride and glibenclamide on paraoxonase 1 and platelet-activating factor acetylohydrolase activity. Life Sci. 2010; 87(3-4): 126-32[DOI][PubMed]
  • 11. Mackness B, Mackness MI, Arrol S, Turkie W, Julier K, Abuasha B, et al. Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus. Atheroscler. 1998; 139(2): 341-9
  • 12. Kiyici A, Okudan N, Gokbel H, Belviranli M. The effect of grape seed extracts on serum paraoxonase activities in streptozotocin-induced diabetic rats. J Med Food. 2010; 13(3): 725-8[DOI][PubMed]
  • 13. Koren-Gluzer M, Aviram M, Meilin E, Hayek T. The antioxidant HDL-associated paraoxonase-1 (PON1) attenuates diabetes development and stimulates beta-cell insulin release. Atherosclerosis. 2011; 219(2): 510-8[DOI][PubMed]
  • 14. Baliga MS, Baliga BRV, Kandathil SM, Bhat HP, Vayalil PK. A review of the chemistry and pharmacology of the date fruits (Phoenix dactylifera L.). Food Res Int. 2011; 44(7): 1812-22
  • 15. Al-Farsi MA, Lee CY. Nutritional and functional properties of dates: a review. Crit Rev Food Sci Nutr. 2008; 48(10): 877-87[DOI][PubMed]
  • 16. Vayalil PK. Date fruits (Phoenix dactylifera Linn): an emerging medicinal food. Crit Rev Food Sci Nutr. 2012; 52(3): 249-71[DOI][PubMed]
  • 17. Soong YY, Barlow PJ. Antioxidant activity and phenolic content of selected fruit seeds. Food Chem. 2004; 88(3): 411-7
  • 18. Al-Farsi MA, Lee CY. Optimization of phenolics and dietary fibre extraction from date seeds. Food Chem. 2008; 108(3): 977-85[DOI]
  • 19. Besbes S, Blecker C, Deroanne C, Drira NE, Attia H. Date seeds: chemical composition and characteristic profiles of the lipid fraction. Food Chem. 2004; 84(4): 577-84[DOI]
  • 20. Nguyen SD, Sok DE. Oxidative inactivation of paraoxonase1, an antioxidant protein and its effect on antioxidant action. Free Radic Res. 2003; 37(12): 1319-30
  • 21. Ng CJ, Shih DM, Hama SY, Villa N, Navab M, Reddy ST. The paraoxonase gene family and atherosclerosis. Free Radic Biol Med. 2005; 38(2): 153-63[DOI][PubMed]
  • 22. Mirdamadi HZ, Sztanek F, Derdak Z, Seres I, Harangi M, Paragh G. The human paraoxonase-1 phenotype modifies the effect of statins on paraoxonase activity and lipid parameters. Br J Clin Pharmacol. 2008; 66(3): 366-74[DOI][PubMed]
  • 23. Kassai A, Illyes L, Mirdamadi HZ, Seres I, Kalmar T, Audikovszky M, et al. The effect of atorvastatin therapy on lecithin:cholesterol acyltransferase, cholesteryl ester transfer protein and the antioxidant paraoxonase. Clin Biochem. 2007; 40(1-2): 1-5[DOI][PubMed]
  • 24. Dullaart RP, de Vries R, Voorbij HA, Sluiter WJ, van Tol A. Serum paraoxonase-I activity is unaffected by short-term administration of simvastatin, bezafibrate, and their combination in type 2 diabetes mellitus. Eur J Clin Invest. 2009; 39(3): 200-3[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments